A Phase 1, Open-label, Parallel Group, Drug-drug Pharmacokinetic Interaction Study to Evaluate the Effects of Multiple-dose Omeprazole and Famotidine on the Absorption of Single-dose Telotristat Ethyl in Healthy Male and Female Subjects
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Telotristat etiprate (Primary) ; Famotidine; Omeprazole
- Indications Malignant carcinoid syndrome
- Focus Pharmacokinetics
- Sponsors Lexicon Pharmaceuticals
- 06 Feb 2018 Planned End Date changed from 19 Nov 2017 to 28 Feb 2018.
- 06 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 09 Oct 2017 New trial record